Promoter holding
64.27%
MD
Molbio Diagnostics Limited - Due diligence report
A 360° intelligence report on Molbio: trust score, financial health, credit view, compliance, directors, growth and distress signals - gener…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Molbio — 360° Intelligence Report
Generated from MCA filings & public records72/100
Trust Score
Moderate
Molbio is assessed as Moderate with a Trust Score of 72/100. Molbio is an active public limited indian non-government company incorporated in 2000, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 23 Jun 2026 from the latest processed filings. Molbio Diagnostics Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
82/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
30/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 9 open (548.35 cr) · 7 satisfied (260.62 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 11 | 48.0 cr |
| Yes Bank Limited | 1 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
| Axis Bank Limited | 2 | 48.0 cr |
| Tata Capital Financial Services Limited | 1 | 48.0 cr |
Compliance Score: 82/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- 1 auditor resignation(s) filed - latest: VINUTA & CO on 2021-03-26.
- Delayed payments to MSME suppliers disclosed (386 disclosure(s)).
- 7 active GST registration(s).
05
Director Intelligence
Stability score: 30/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ARUNKUMAR JHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHANDRASEKHAR BHASKARAN NAIR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Balram Bhargava | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NUPUR GARG | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SRIRAM NATARAJAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANGEETHA SRIRAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Darshan Raghunath Karekar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- ARUNKUMAR JHA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 4 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
4
Group entities
5
Capital events
8 allotment(s) · 24 transfer(s)
Promoters hold the largest single block of equity - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Bigtec Healthcare Private Limited | Subsidiary Company | 74.00% |
| Bigtec Private Limited | Subsidiary Company | 74.00% |
| Deciphar Life Sciences Private Limited | Subsidiary Company | 74.00% |
| Remfuel Bioenergy Private Limited | Subsidiary Company | 74.00% |
| Prognosys Medical Systems Private Limited | Associate Company | 74.00% |
Key managerial personnel: SRIRAM NATARAJAN (CEO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 75 · Distress 55
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 25+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
3 director exits within 2 years.
9 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 68.18 Lakh.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence71/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment80/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 9 open charge(s) of 548.35 cr already registered.
- Compliance record supports lending.
Investor view76/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events09 Dec 2025
Director ceased
Amol Narayan Lone
25 Oct 2025
Charge created
Others - 225.90 cr
11 Aug 2025
Last AGM held
Annual general meeting
10 Aug 2025
Director ceased
VED PRAKASH KALANORIA
Director ceased
NUPUR GARG
31 Mar 2025
Latest balance sheet
Filed with ROC
27 Feb 2025
Charge created
Axis Bank Limited - 45.00 cr
07 Feb 2025
Charge satisfied
Others
31 Jan 2025
Director appointed
NUPUR GARG (Director)
09 Dec 2024
Charge satisfied
Others
16 Nov 2024
Director appointed
ARUNKUMAR JHA (Director)
Director appointed
Balram Bhargava (Director)
13 Sep 2024
Director appointed
Darshan Raghunath Karekar (Company Secretary)
25 Jul 2024
Charge created
Others - 2.75 cr
17 Jul 2024
Charge created
Others - 2.75 cr
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
7 active director(s) / partner(s); review board churn before relying on management continuity.
7 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 4 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 8 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Grow Indigo | U01100MH2018PTC304488 | Mumbai, Maharashtra, India |
| Safex Fire Services | U29193MH2000PLC127212 | Mumbai, Maharashtra, India |
| Lntmbda | U29308MH2017PLC293402 | Mumbai, Maharashtra, India |
| Vasudeva Dhal Products Private Limited | U15313AP2010PTC071985 | Vijayawada, Andhra Pradesh, India |
| Bbtcl | L99999MH1863PLC000002 | Na, Maharashtra, India |
| House Of Bnm Private Limited | U36109MH2022PTC389243 | Mumbai, Maharashtra, India |
| Hreenkar Creations Private Limited | U36911MH2021PTC354430 | Mumbai, Maharashtra, India |
| Sky Chains And Jewellery Private Limited | U36911MH2011PTC214755 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Molbio before audits and certifications: compliance score 82/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Molbio: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Molbio - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Molbio pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Molbio - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Molbio an active company?
Molbio has MCA status “Active” with a compliance score of 82/100 (Low Risk).
Is Molbio financially healthy?
Molbio has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Molbio?
Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Molbio?
Promoters hold the largest single block of equity - exact percentages are in the full report. 7 active director(s) are on record.
Does Molbio have loans or charges against its assets?
9 open charge(s) are registered against its assets, and 7 earlier charge(s) stand satisfied.
Is Molbio up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 82/100 (Low Risk).
Is it risky to lend to Molbio?
Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
